Application of poly(ethylene glycol)–distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery

References

• ZhangLChanJMGuFXSelf-assembled lipid- polymer hybrid nanoparticles: a robust drug delivery platformACS Nano2008281696170219206374
   PubMed Web of Science ®Google Scholar
• Dos SantosNAllenCDoppenAMInfluence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein bindingBiochim Biophys Acta2007176861367137717400180
   PubMed Web of Science ®Google Scholar
• YamadaATaniguchiYKawanoKHondaTHattoriYMaitaniYDesign of folate-linked liposomal doxorubicin to its antitumor effect in miceClin Cancer Res200814248161816819088031
   PubMed Web of Science ®Google Scholar
• SriwongsitanontSUenoMEffect of a PEG lipid (DSPE-PEG2000) and freeze-thawing process on phospholipid vesicle size and lamellarityColloid Polym Sci20042827753760
   Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev200456111649165915350294
   PubMed Web of Science ®Google Scholar
• SongSLiuDPengJPeptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivoInt J Pharm20083631–215516118692120
   PubMed Web of Science ®Google Scholar
• KangHO’DonoghueMBLiuHTanWA liposome-based nanostructure for aptamer directed deliveryChem Commun2010462249251
   PubMed Web of Science ®Google Scholar
• SuJCTsengCLChangTGYuWJWuSKA synthetic method for peptide-PEG-lipid conjugates: application of octreotide-PEG-DSPE synthesisBioorg Med Chem Lett200818164593459618656351
   PubMed Web of Science ®Google Scholar
• KarathanasisEGeigermanCMParkosCAChanLBellamkondaRVJayeDLSelective targeting of nanocarriers to neutrophils andmonocytesAnn Biomed Eng200937101984199219387833
   PubMed Web of Science ®Google Scholar
• VaidyaBAgrawalGVyasSPPlatelets directed liposomes for the delivery of streptokinase: development and characterizationEur J Pharm Sci201144558959422009110
   PubMed Web of Science ®Google Scholar
• IshidaOMaruyamaKTanahashiHLiposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivoPharm Res20011871042104811496943
   PubMed Web of Science ®Google Scholar
• Lopez-BarconsLAPoloDReigFFabraAPentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomesJ Biomed Mater Res A200469A115516314999763
   PubMed Web of Science ®Google Scholar
• OtsuboTMaruyamaKMaesakiSLong-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in miceAntimicrob Agents Chemother199842140449449258
   PubMed Web of Science ®Google Scholar
• MaruyamaKTakizawaTYudaTKennelSJHuangLIwatsuruMTargetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodiesBiochim Biophys Acta19951234174807880861
   PubMed Web of Science ®Google Scholar
• ZalipskySBrandeisENewmanMSWoodleMCLong circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamineFEBS Lett1994353171747926026
   PubMed Web of Science ®Google Scholar
• GorenDHorowitzAZalipskySWoodleMYardenYGabizonATargeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studiesBr J Cancer19967411174917568956788
   PubMed Web of Science ®Google Scholar
• KoningGAMorseltHWMGorterAInteraction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparisonPharm Res20032081249125712948023
   PubMed Web of Science ®Google Scholar
• ZalipskySSynthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomesBioconjug Chem1993442962998218486
   PubMed Web of Science ®Google Scholar
• CuongNVHsiehMFMolecular targeting of liposomal nanoparticles to lymphatic systemCurr Cancer Drug Targets201111214715521158721
   PubMed Web of Science ®Google Scholar
• PanXWuGYangWBarthRFTjarksWLeeRJSynthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFRBioconjug Chem200718110110817226962
   PubMed Web of Science ®Google Scholar
• KoningGAKampsJAAMScherphofGLEfficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomesCancer Detect Prev200226429930712430634
   PubMedGoogle Scholar
• LuRMChangYLChenMSWuHCSingle chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug deliveryBiomaterials201132123265327421306768
   PubMed Web of Science ®Google Scholar
• KibriaGHatakeyamaHOhgaNHidaKHarashimaHDual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene deliveryJ Control Release2011153214114821447361
   PubMed Web of Science ®Google Scholar
• KirpotinDParkJWHongKSterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitroBiochemistry199736166758993319
   PubMed Web of Science ®Google Scholar
• GabizonAHorowitzATGorenDTargeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studiesBioconjugate Chem1999102289298
   PubMed Web of Science ®Google Scholar
• ZhaoBJKeXYHuangYThe antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in ratsJ Drug Target201119538239020677914
   PubMed Web of Science ®Google Scholar
• YamanoSDaiJYuviencoCKhapliSMoursiAMMontclareJKModified Tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosisJ Control Release2011152227828521315780
   PubMed Web of Science ®Google Scholar
• TurkMJBreurGJWidmerWRFolate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritisArthritis Rheum20024671947195512124880
   PubMed Web of Science ®Google Scholar
• GabizonATzemachDGorinJImproved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor modelsCancer Chemother Pharmacol2010661435219779718
   PubMed Web of Science ®Google Scholar
• RiviereKHuangZJergerKMacaraegNSzokaFCAntitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administrationJ Drug Target2011191142420353291
   PubMed Web of Science ®Google Scholar
• AllenTMLigand-targeted therapeutics in anticancer therapyNat Rev Cancer200221075076312360278
   PubMed Web of Science ®Google Scholar
• ChiuSJMarcucciGLeeRJEfficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomesAnticancer Res2006262A1049105616619505
   PubMed Web of Science ®Google Scholar
• DoiAKawabataSIidaKTumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapyJ Neurooncol200887328729418219552
   PubMed Web of Science ®Google Scholar
• YangXKohCGLiuSTransferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2Mol Pharm20086122123019183107
   PubMed Web of Science ®Google Scholar
• TakaraKHatakeyamaHOhgaNHidaKHarashimaHDesign of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptakeInt J Pharm20103961–214314820457236
   PubMed Web of Science ®Google Scholar
• SongSLiuDPengJNovel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivoFASEB J20092351396140419124558
   PubMed Web of Science ®Google Scholar
• ZhuJXueJGuoZZhangLMarchantREBiomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated plateletsBioconjug Chem20071851366136917691854
   PubMed Web of Science ®Google Scholar
• MorilleMPassiraniCLetrou-BonnevalEBenoitJPPitardBGalactosylated DNA lipid nanocapsules for efficient hepatocyte targetingInt J Pharm2009379229330019505548
   PubMed Web of Science ®Google Scholar
• XiongXBHuangYLuWLIntracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: In vitro and in vivoJ Pharm Sci20059481782179315986461
   PubMed Web of Science ®Google Scholar
• JiangJYangSWangJSequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicinEur J Pharm Biopharm201076217017820600887
   PubMed Web of Science ®Google Scholar
• LiSDHuangLTargeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cellsMol Pharm20063557958817009857
   PubMed Web of Science ®Google Scholar
• ÖnyükselHMohantyPSRubinsteinIVIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancerInt J Pharm20093651–215716118793708
   PubMed Web of Science ®Google Scholar
• ThieHMeyerTSchirrmannTHustMDubelSPhage display derived therapeutic antibodiesCurr Pharm Biotechnol20089643944619075684
   PubMed Web of Science ®Google Scholar
• CarterPImproving the efficacy of antibody-based cancer therapiesNat Rev Cancer20011211812911905803
   PubMed Web of Science ®Google Scholar
• MaynardJGeorgiouGAntibody engineeringAnnu Rev Biomed Eng20002133937611701516
   PubMed Web of Science ®Google Scholar
• SapraPAllenTMImproved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopesClin Cancer Res20041072530253715073133
   PubMed Web of Science ®Google Scholar
• O’DonnellRMartinSMaYZamboniWTuscanoJDevelopment and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)Invest New Drug2010283260267
   Web of Science ®Google Scholar
• Lopes de MenezesDEPilarskiLMAllenTMIn vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphomaCancer Res19985815332033309699662
   PubMed Web of Science ®Google Scholar
• MamotCDrummondDCGreiserUEpidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR-and EGFRvIII-overexpressing tumor cellsCancer Res200363123154316112810643
   PubMed Web of Science ®Google Scholar
• RothdienerMMüllerDCastroPGTargeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systemsJ Control Release2010144225125820184933
   PubMed Web of Science ®Google Scholar
• HayesMDrummondDKirpotinDGenospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene deliveryGene Ther200513764665116341056
   PubMed Web of Science ®Google Scholar
• MaruyamaKTakahashiNTagawaTNagaikeKIwatsuruMImmunoliposomes bearing polyethyleneglycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivoFEBS Lett199741311771809287139
   PubMed Web of Science ®Google Scholar
• ChengWWKAllenTMTargeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab′ fragments and single chain FvJ Control Release20081261505818068849
   PubMed Web of Science ®Google Scholar
• AllenTMMumbengegwiDRCharroisGJRAnti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release ratesClin Cancer Res20051193567357315867261
   PubMed Web of Science ®Google Scholar
• LapalombellaRYuBTriantafillouGLenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cellsBlood2008112135180518918772452
   PubMed Web of Science ®Google Scholar
• TuscanoJMMartinSMMaYZamboniWO’DonnellRTEfficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non–Hodgkin’s lymphoma xenograft mouse modelClin Cancer Res201016102760276820460479
   PubMed Web of Science ®Google Scholar
• DrummondDCMarxCGuoZEnhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomesClin Cancer Res20051193392340115867240
   PubMed Web of Science ®Google Scholar
• NielsenUBKirpotinDBPickeringEMTherapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosisBiochim Biophys Acta200215911–310911812183061
   PubMed Web of Science ®Google Scholar
• HuCMJKaushalSCaoHSTHalf-antibody functionalized lipid–polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cellsMol Pharm20107391492020394436
   PubMed Web of Science ®Google Scholar
• MaruyamaKTakizawaTTakahashiNTagawaTNagaikeKIwatsuruMTargeting efficiency of PEG-immunoliposome-conjugated antibodies at PEG terminalsAdv Drug Deliv Rev1997242–3235242
   Web of Science ®Google Scholar
• MoreiraJNGasparRAllenTMTargeting Stealth liposomes in a murine model of human small cell lung cancerBiochim Biophys Acta20011515216717611718672
   PubMed Web of Science ®Google Scholar
• MoreiraJNIshidaTGasparRAllenTMUse of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicityPharm Res200219326526911934232
   PubMed Web of Science ®Google Scholar
• Bohl KullbergEBergstrandNCarlssonJDevelopment of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agentsBioconjug Chem200213473774312121128
   PubMed Web of Science ®Google Scholar
• PastorinoFBrignoleCMarimpietriDDoxorubicin-loaded Fab′ fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude miceCancer Res2003631869212517782
   PubMed Web of Science ®Google Scholar
• KoningGAMorseltHWMGorterAPharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastasesPharm Res20011891291129811683242
   PubMed Web of Science ®Google Scholar
• HuangLKennelSJBinding of immunoglobulin G to phospholipid vesicles by sonicationBiochemistry197918917021707571288
   PubMed Web of Science ®Google Scholar
• NobsLBucheggerFGurnyRAllémannECurrent methods for attaching targeting ligands to liposomes and nanoparticlesJ Pharm Sci20049381980199215236448
   PubMed Web of Science ®Google Scholar
• YanZWangFWenZLyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumorJ Control Release2011157111812521827801
   PubMed Web of Science ®Google Scholar
• GillKNazzalSKaddoumiAPaclitaxel loaded PEG (5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluationEur J Pharm Biopharm201179227628421575719
   PubMed Web of Science ®Google Scholar
• XuZZhangZChenYChenLLinLLiYThe characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma modelBiomaterials201031591692219846217
   PubMed Web of Science ®Google Scholar
• HanXLiuJLiuM9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitroInt J Pharm20093721–212513119166923
   PubMed Web of Science ®Google Scholar
• ShmeedaHAmitayYGorinJDelivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cellsJ Control Release20101461768320462513
   PubMed Web of Science ®Google Scholar
• IshidaTIdenDLAllenTMA combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugsFEBS Lett1999460112913310571074
   PubMed Web of Science ®Google Scholar
• AllenTMSapraPMoaseEUse of the post-insertion method for the formation of ligand-coupled liposomesCell Mol Biol Lett20027221721912097921
   PubMed Web of Science ®Google Scholar
• IdenDLAllenTMIn vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approachBiochim Biophys200115132207216
   Web of Science ®Google Scholar
• VaderPCrielaardBJvan DommelenSMvan der MeelRStormGSchiffelersRMTargeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particlesJ Control Release2011160221121621983283
   PubMed Web of Science ®Google Scholar
• WoodleMCLasicDDSterically stabilized liposomesBiochim Biophys Acta1992111321711991510996
   PubMed Web of Science ®Google Scholar
• Bakker-WoudenbergIAJMLong-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious fociInt J Antimicrob Agents200219429931111978501
   PubMed Web of Science ®Google Scholar
• AllenCDos SantosNGallagherRControlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly (ethylene glycol)Biosci Rep200222222525012428902
   PubMed Web of Science ®Google Scholar
• AllenTMHansenCRutledgeJLiposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissuesBiochim Biophys Acta1989981127352719971
   PubMed Web of Science ®Google Scholar
• KimKYuMZongXControl of degradation rate and hydrophilicity in electrospun non-woven poly(d,l-lactide) nanofiber scaffolds for biomedical applicationsBiomaterials200324274977498514559011
   PubMed Web of Science ®Google Scholar
• GrefRLückMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
   PubMed Web of Science ®Google Scholar
• BradleyAJMuradKLReganKLScottMDBiophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matterBiochim Biophys Acta20021561214715811997115
   PubMed Web of Science ®Google Scholar
• ZhuALuPWuHImmobilization of poly(-caprolactone)-poly(ethylene oxide)-poly(-caprolactone) triblock copolymer on poly(lactide-co-glycolide) surface and dual biofunctional effectsAppl Surf Sci2007253632473253
   Web of Science ®Google Scholar
• PapahadjopoulosDAllenTGabizonASterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacyProc Natl Acad Sci U S A1991882411460114641763060
   PubMed Web of Science ®Google Scholar
• AllenTMHansenCMartinFRedemannCYau-YoungALiposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochim Biophys1991106612936
   PubMed Web of Science ®Google Scholar
• NewmanMSColbernGTWorkingPKEngbersCAmanteaMAComparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing miceCancer Chemother Pharm199943117
   PubMed Web of Science ®Google Scholar
• KumariAYadavSKYadavSCBiodegradable polymeric nanoparticles based drug delivery systemsColloids Surf B Biointerfaces201075111819782542
   PubMed Web of Science ®Google Scholar
• KataokaKHaradaANagasakiYBlock copolymer micelles for drug delivery: design, characterization and biological significanceAdv Drug Deliv Rev200147111313111251249
   PubMed Web of Science ®Google Scholar
• GuoJGaoXSuLAptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug deliveryBiomaterials201132318010802021788069
   PubMed Web of Science ®Google Scholar
• YangXZDouSSunTMMaoCQWangHXWangJSystemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapyJ Control Release2011156220321121839126
   PubMed Web of Science ®Google Scholar
• DiaoYYLiHYFuYHDoxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cellsInt J Nanomed2011619551962
   PubMed Web of Science ®Google Scholar
• ShiJXiaoZKamalyNFarokhzadOCSelf-assembled targeted nanoparticles: evolution of technologies and bench to bedside translationAcc Chem Res201144101123113421692448
   PubMed Web of Science ®Google Scholar
• HattoriYMaitaniYEnhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancerJ Control Release200497117318315147814
   PubMed Web of Science ®Google Scholar
• HanXLiuJLiuM9-nitro-camptothecin-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitroInt J Pharm20093721–212513119166923
   PubMed Web of Science ®Google Scholar
• WangJMaitaniYTakayamaKAntitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipidJ Pharm Sci20029141128113411948551
   PubMed Web of Science ®Google Scholar
• StevensPJLeeRJA folate receptor-targeted emulsion formulation for paclitaxelAnticancer Res2003236C4927493114981947
   PubMed Web of Science ®Google Scholar
• ShiokawaTHattoriYKawanoKEffect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivoClin Cancer Res20051152018202515756028
   PubMed Web of Science ®Google Scholar
• JunpingWTakayamaKNagaiTMaitaniYPharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterolInt J Pharm20032511–2132112527171
   PubMed Web of Science ®Google Scholar
• ZhangLChanJMGuFXSelf-assembled lipid–polymer hybrid nanoparticles: a robust drug delivery platformACS Nano2008281696170219206374
   PubMed Web of Science ®Google Scholar
• PrakashSMalhotraMShaoWTomaro-DuchesneauCAbbasiSPolymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapyAdv Drug Deliv Rev20116314–151340135121756952
   PubMed Web of Science ®Google Scholar
• ChanJMZhangLYuetKPPLGA-lecithin-PEG core-shell nanoparticles for controlled drug deliveryBiomaterials20093081627163419111339
   PubMed Web of Science ®Google Scholar
• WongHLBendayanRRauthAMXueHYBabakhanianKWuXYA mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle systemJ Pharmacol Exp Ther200631731372138116547167
   PubMed Web of Science ®Google Scholar
• MüllerRRadtkeMWissingSSolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254S131S15512460720
   PubMed Web of Science ®Google Scholar
• MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• StevensPJSekidoMLeeRJSynthesis and evaluation of a hematoporphyrin derivative in a folate receptor-targeted solid-lipid nanoparticle formulationAnticancer Res200424116116515015592
   PubMed Web of Science ®Google Scholar
• KuoYCLiangCTCatanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cellsColloids Surf B Biointerfaces201185213113721411296
   PubMed Web of Science ®Google Scholar
• HayesMDrummondDHongKParkJMarksJKirpotinDAssembly of nucleic acid-lipid nanoparticles from aqueous-organic monophasesBiochim Biophys Acta20061758442944216678786
   PubMed Web of Science ®Google Scholar
• DassCRChoongPFMSelective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicabilityJ Control Release2006113215516316764960
   PubMed Web of Science ®Google Scholar
• KimJKChoiSHKimCOParkJSAhnWSKimCKEnhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiencyJ Pharm Pharmacol200355445346012803766
   PubMed Web of Science ®Google Scholar
• OwensDEIIIPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMed Web of Science ®Google Scholar
• ZuhornISEngbertsJBFNHoekstraDGene delivery by cationic lipid vectors: overcoming cellular barriersEur Biophys J200736434936217019592
   PubMed Web of Science ®Google Scholar
• StuartDDKaoGYAllenTMA novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1Adv Exp Med Biol200073466475
   Google Scholar
• GuraTAfter a setback, gene therapy progresses . . . gingerlyScience200129155091692169711253191
   PubMed Web of Science ®Google Scholar
• KohnDBSadelainMGloriosoJCOccurrence of leukaemia following gene therapy of X-linked SCIDNat Rev Cancer20033747748812835668
   PubMed Web of Science ®Google Scholar
• ThayerAMImproving peptidesChem Eng News201189221320
   Web of Science ®Google Scholar
• LuYYangJSegaEIssues related to targeted delivery of proteins and peptidesAAPS J200683466478
   Web of Science ®Google Scholar
• WoodleMCStormGNewmanMSProlonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro ratPharm Res1992922602651553352
   PubMed Web of Science ®Google Scholar
• LimSBRubinsteinIÖnyükselHFreeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicellesInt J Pharm20083561–234535018289811
   PubMed Web of Science ®Google Scholar
• LajavardiLBochotACameloSDownregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal peptide encapsulated in liposomesInvest Ophthalmol Vis Sci20074873230323817591893
   PubMed Web of Science ®Google Scholar
• KibriaGHatakeyamaHHarashimaHA new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand systemInt J Pharm20114121–210611421414394
   PubMed Web of Science ®Google Scholar
• ChengCJSaltzmanWMEnhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptidesBiomaterials201132266194620321664689
   PubMed Web of Science ®Google Scholar
• ZhaiGWuJYuBGuoCYangXLeeRJA transferrin receptor-targeted liposomal formulation for docetaxelJ Nanosci Nanotechnol20101085129513621125861
   PubMed Web of Science ®Google Scholar
• VladimirPTStructure and design of polymeric surfactant-based drug delivery systemsJ Control Release2001732–313717211516494
   PubMed Web of Science ®Google Scholar
• XiongXBHuangYLuWIEnhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimeticJ Control Release2005107226227516125816
   PubMed Web of Science ®Google Scholar
• JudgeAMcClintockKPhelpsJRMacLachlanIHypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomesMol Ther200613232833716275098
   PubMed Web of Science ®Google Scholar
• IshidaTMaedaRIchiharaMIrimuraKKiwadaHAccelerated clearance of PEGylated liposomes in rats after repeated injectionsJ Control Release2003881354212586501
   PubMed Web of Science ®Google Scholar
• DamsELavermanPOyenWJGAccelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomesJ Pharmacol Exp Ther200029231071107910688625
   PubMed Web of Science ®Google Scholar